Virbac operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Virbac with three other
companies in this sector in France:
sales of 604.21 million Euro [US$683.50 million]
(789.60 million Euro [US$893.21 million]
(367.90 million Euro [US$416.18 million]
Virbac reported sales of 868.80 million Euro (US$982.80 million)
December of 2018.
a very small
increase of 0.8%
versus 2017, when the company's sales were 861.88 million Euro.
Despite this increase, sales are still
below the level achieved in 2016, when Virbac
reported sales of 871.83 million Euro.